Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.3%

1 terminated/withdrawn out of 43 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

14%

6 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

19 recruiting

Enrollment Performance

Analytics

N/A
18(50.0%)
Phase 2
7(19.4%)
Phase 3
6(16.7%)
Phase 1
4(11.1%)
Early Phase 1
1(2.8%)
36Total
N/A(18)
Phase 2(7)
Phase 3(6)
Phase 1(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials
NCT06823128Not ApplicableTerminated

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Severe Stenosis or Occlusion of Anterior Intracranial Circulation Vessels

Role: lead

NCT05827042Phase 3Recruiting

Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

Role: lead

NCT07094763Not ApplicableRecruiting

Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset

Role: lead

NCT07556120Phase 1Not Yet Recruiting

Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)

Role: collaborator

NCT06801119Phase 1Recruiting

Efficacy and Safety of HN2301 in Autoimmune Diseases(AIDs)

Role: collaborator

NCT07523282Phase 1Not Yet Recruiting

Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases

Role: collaborator

NCT07452848Recruiting

Impact of Pringle Maneuver on Postoperative Gallbladder Diseases After Hepatectomy

Role: collaborator

NCT07449910Phase 2Not Yet Recruiting

Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial

Role: lead

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT05701956Phase 3Completed

Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion

Role: lead

NCT03664518Phase 2Completed

to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection

Role: collaborator

NCT05416853Not ApplicableActive Not Recruiting

Radial Versus Femoral Access For Carotid Artery Stenting

Role: lead

NCT07309705Active Not Recruiting

Digital Angiography-Derived Fractional Flow Assessment for Intracranial Stenosis

Role: collaborator

NCT07157631Not ApplicableRecruiting

Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial

Role: collaborator

NCT07230574Phase 2Not Yet Recruiting

Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure

Role: collaborator

NCT07214142Phase 2Not Yet Recruiting

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

Role: lead

NCT07168278Phase 3Not Yet Recruiting

Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT

Role: lead

NCT04669496Phase 2Active Not Recruiting

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Role: collaborator

NCT06871839Recruiting

The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

Role: collaborator

NCT07012694Not ApplicableNot Yet Recruiting

22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions

Role: collaborator